tbuckley/cabot-search huggingface dataset:
PD-0032 Preoperative Chemoradiation for Resectable Adenocarcinoma of the Pancreas (ISRCTN 78805636): Pattern of Recurrence.
Authors: Henriette Golcher, Helmut Witzigmann, Lukas Marti, Jochen Lange, Wolf Bechstein, Christiane Bruns, Henry Jungnickel, Johann Hauss, Stefan Schreiber, Thomas Brunner, Gerhard Grabenbauer, Susanne Merkel, Rainer Fietkau, Werner Hohenberger
Journal: Annals of Oncology (2012)
Sorafenib in Patients with Renal Cell Carcinoma and Brain, Bone or Lung Metastases: Subanalysis of the Non-Interventional Predict Study
Authors: J. Mardiak, J. Ma, E. Korbenfeld, M. Zemanova, N. Leonhartsberger, K. Stauch, A. Boeckenhoff, J. Yu, B. Escudier, D. Jäger
Journal: Annals of Oncology (2012)
A Multicenter Phase II Study of Bendamustine with Rituximab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: W.S. Kim, K. Ando, N. Niitsu, M. Ogura, N. Takahashi, N. Uike, H. Seok Eom, Y.S. Chae, K. Tobinai, T. Terauchi, U. Tateishi, M. Tatsumi, C. Suh
Journal: Annals of Oncology (2012)
Metabolic flexibility is impaired in women who are pregnant and overweight/obese and related to insulin resistance and inflammation
Authors: Rachel A. Tinius, Maire M. Blankenship, Karen E. Furgal, W. Todd Cade, Kevin J. Pearson, Naomi S. Rowland, Regis C. Pearson, Donald L. Hoover, Jill M. Maples
Journal: Metabolism (2020)
Morbidity in Advanced Basal Cell Carcinoma (BCC) and BCC Nevus Syndrome (BCCNS) from the Patient (PT) and Physician Perspective: Development of a Patient-Reported Outcome (PRO) Questionnaire
Authors: S.D. Mathias, M. Chren, Y.M. Yim, H. Colwell, C. Reyes, D.M. Chen, S.W. Fosko
Journal: Annals of Oncology (2012)
PI3K Kinase Inhibitor GSK2126458 (GSK458): Clinical Activity in Select Patient (PT) Populations Defined by Predictive Markers (STUDY P3K112826)
Authors: P. Munster, R. van der Noll, E. Voest, J. Specht, T.L. Werner, E.C. Dees, A.R. Tan, A. Daud, J. Schellens, M.P. Lolkema, M. Griffin, N. Agarwal, G.S. Falchook, J.F. Kleha, M. Durante, D.A. Smith, L. Adams, J. Greshock, S.R. Morris, R. Kurzrock
Journal: Annals of Oncology (2012)
Prognostic Factors of Renal Collecting Duct Carcinoma based on Clinical Features and Effective Chemotherapy
Authors: K.A. Kwon, S.Y. Oh, H.Y. Kim, T.M. Kim, H.Y. Lim, N.-R. Lee, H.J. Lee, S.H. Hong, S.Y. Rha
Journal: Annals of Oncology (2012)
A unified approach to loneliness
Authors: Linda Fried, Thomas Prohaska, Vanessa Burholt, Annette Burns, Jeannette Golden, Louise Hawkley, Brian Lawlor, Gerard Leavey, Jim Lubben, Roger O'Sullivan, Carla Perissinotto, Theo van Tilburg, Mark Tully, Christina Victor
Journal: The Lancet (2020)
Reform at the FDA—In Need of Reform
Authors: Joshua M. Sharfstein
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Second Line Treatment in Metastatic Papillary Renal Cell Carcinoma: Retrospective Analysis of a 48 Patients Cohort
Authors: L. Albiges, F. Riet, C. Massard, S. Le Moulec, Y. Loriot, A. Levy, K. Fizazi, B. Escudier
Journal: Annals of Oncology (2012)
Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer
Authors: R.D. Nipp, N.K. Horick, A.M. Deal, L.J. Rogak, C. Fuh, J.A. Greer, A.C. Dueck, E. Basch, J.S. Temel, A. El-Jawahri
Journal: Annals of Oncology (2020)
Proof of Concept of Gene Therapy Using Plasmid Amep in Disseminated Melanoma: Safety and Efficacy Results of A Phase I First-In-Man Study
Authors: I. Spanggaard, M. Snoj, A. Cavalcanti, C. Bouquet, G. Sersa, C. Robert, B. Vasseur, P. Attali, L.M. Mir, J. Gehl
Journal: Annals of Oncology (2012)
Abstract 12578: Stroke Prophylaxis After US Emergency Department Diagnosis and Discharge of Patients With Atrial Fibrillation and Flutter
Authors: Bory Kea, E. Margaret E Warton, Benjamin C Sun, Brian Olshansky, Gregory Y Lip, Merritt Raitt, Mary E Reed, Dustin W Ballard, David R Vinson
Journal: Circulation (2019)

Introduction: Oral anticoagulation (OAC) reduces stroke and mortality risk in patients with nonvalvular atrial fibrillation/flutter (AF). Patterns of OAC initiation in or after discharge from US em...
Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor
Authors: Jiajun Zhang, Weihai Liu, Changye Zou, Zhiqiang Zhao, Yuanying Lai, Zhi Shi, Xianbiao Xie, Gang Huang, Yongqian Wang, Xuelin Zhang, Zepei Fan, Qiao Su, Junqiang Yin, Jingnan Shen
Journal: Clinical Cancer Research (2020)

Malignancy of cancer cells depends on the active transcription of tumor-associated genes. Recently, unique clusters of transcriptional enhancers, termed super-enhancers, have been reported to drive the expression of genes that define cell identity. In this study, we characterized specific super-enhancer-associated genes of osteosarcoma, and explored their potential therapeutic value.Super-enhancer regions were characterized through chromatin immunoprecipitation sequencing (ChIP-seq). RT-qPCR was used to detect the mRNA level of CDK7 in patient specimens and confirm the regulation of sensitive oncogenes by THZ2. The phosphorylation of the initiation-associated sites of RNA polymerase II (RNAPII) C-terminal repeat domain (CTD) was measured using Western blotting. Microarray expression analysis was conducted to explore transcriptional changes after THZ2 treatment. A variety of in vitro and in vivo assays were performed to assess the effects of CDK7 knockdown and THZ2 treatment in osteosarcoma.Super-enhancers were associated with oncogenic transcripts and key genes encoding cell-type-specific transcription factors in osteosarcoma. Knockdown of transcription factor CDK7 reduced phosphorylation of the RNAPII CTD, and suppressed the growth and metastasis of osteosarcoma. A new specific CDK7 inhibitor, THZ2, suppressed cancer biology by inhibition of transcriptional activity. Compared with typical enhancers, osteosarcoma super-enhancer-associated oncogenes were particular vulnerable to this transcriptional disruption. THZ2 exhibited a powerful anti-osteosarcoma effect in vitro and in vivo.Super-enhancer-associated genes contribute to the malignant potential of osteosarcoma, and selectively targeting super-enhancer-associated oncogenes with the specific CDK7 inhibitor THZ2 might be a promising therapeutic strategy for patients with osteosarcoma.
Rebiopsy of Non-Small-Cell Lung Cancer Patients with Acquired Resistance to EGFR-TKI: Comparison Between T790M Mutation-Positive and -Negative Populations
Authors: A. Hata, N. Katakami, H. Yoshioka, K. Tanaka, A. Nishiyama, S. Nanjo, R. Kaji, S. Fujita, K. Monden, T. Matsumoto, K. Nagata, K. Otsuka, R. Tachikawa, K. Tomii, M. Iwasaku
Journal: Annals of Oncology (2012)
Disease Flare after Gefitinib Discontinuation
Authors: H. Akamatsu, A. Ono, T. Shukuya, A. Tsuya, Y. Nakamura, H. Kenmotsu, T. Naito, H. Murakami, T. Takahashi, M. Endo, T. Nakajima, N. Yamamoto
Journal: Annals of Oncology (2012)
Prospective Evaluation of the Effect of a Manual for Diabetic Patients who Receive Cancer Chemotherapy
Authors: H. Kato, T. Mineta, K. Chikamori, N. Hamajima, S. Koyama, H. Kushihara, B. Hiroyuki, M. Yamauchi, K. Kawada, F. Nomura
Journal: Annals of Oncology (2012)
The Discrepancy Between High Pathological Complete Response (PCR) Rate and Low Breast Conserving Surgery (BCS) Following Neoadjuvant Therapy: Analysis from the Neoaltto Trial (BIG 1-06)
Authors: C. Criscitiello, H.A. Azim, D. Agbor-Tarh, E. De Azambuja, M. Piccart, J. Baselga, H. Eidtmann, S. Di Cosimo, I. Bradbury, I.T. Rubio
Journal: Annals of Oncology (2012)
Phase I Study of Ono-4538 (BMS-936558), An Anti PD-1 Antibody, in Japanese Patients with Advanced Solid Tumors
Authors: N. Yamamoto, Y. Yamada, H. Nokihara, H. Asahina, T. Shibata, Y. Tamura, Y. Seki, K. Honda, Y. Tanabe, T. Tamura
Journal: Annals of Oncology (2012)
Rapid and Accurate Bayesian Diagnosis of Heparin-induced thrombocytopenia
Authors: Matteo Marchetti, Stefano Barelli, Maxime Grégoire Zermatten, Fanny Monnin-Respen, Elena Matthey-Guirao, Nicole Nicolas, Francisco Gomez, Matthew Goodyer, Christiane Gerschheimer, Lorenzo Alberio
Journal: Blood (2020)
P-0005 Microrna-502A (MIR-502A) Post-Transcriptionally Regulates ERBB4 and INHIBITS Cell Proliferation in Esophageal Squamous Cell Carcinoma
Authors: Mingxin Zhang, Suna Zhou, Lingmin Zhang, Jia Zhang, Jiansheng Wang, Chen Huang
Journal: Annals of Oncology (2012)
Brown Fat Seen on FDG PET/CT is Increased in Breast Cancer Patients Compared to their Age- and Weight-Matched Controls With Other Cancers
Authors: K.H.R. Tkaczuk, Q. Cao, L. Jones, M. Smith, S. Chumsri, J. Jenkins, V. Dilsizian, W. Chen
Journal: Annals of Oncology (2012)
Molecular Evolutionary Genetics Analysis (MEGA) for macOS
Authors: Glen Stecher, Koichiro Tamura, Sudhir Kumar
Journal: Molecular Biology and Evolution (2019)

Abstract The Molecular Evolutionary Genetics Analysis (MEGA) software enables comparative analysis of molecular sequences in phylogenetics and evolutionary medicine. Here, we introduce the macOS version of the MEGA software. This new version eliminates the need for virtualization and emulation programs previously required to use MEGA on Apple computers. MEGA for macOS utilizes memory and computing resources efficiently for conducting evolutionary analyses on macOS. It has a native Cocoa graphical user interface that is programmed to provide a consistent user experience across macOS, Windows, and Linux. MEGA for macOS is available from www.megasoftware.net free of charge.
Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial
Authors: Alexandra Vent, Christian Surber, Nicole Tracy Graf Johansen, Verena Figueiredo, Georg Schönbächler, Laurence Imhof, Caroline Buset, Jürg Hafner
Journal: Journal of the American Academy of Dermatology (2020)
Multicenter Randomized Phase II Study of Weekly Docetaxel Alone Versus Weekly Docetaxel Plus Oxaliplatin as a Second-Line Chemotherapy in Patients with Advanced Gastric Cancer: Preliminary Response and Safety Results
Authors: J.Y. Kim, Y.R. Do, K.U. Park, H.-M. Ryoo, S.H. Bae, Y.S. Chae, M.K. Kim, K.H. Lee, S.A. Lee, J.G. Kim, H.-S. Song
Journal: Annals of Oncology (2012)
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer
Authors: Karuna Ganesh, Harihar Basnet, Yasemin Kaygusuz, Ashley M. Laughney, Lan He, Roshan Sharma, Kevin P. O’Rourke, Vincent P. Reuter, Yun-Han Huang, Mesruh Turkekul, Ekrem Emrah Er, Ignas Masilionis, Katia Manova-Todorova, Martin R. Weiser, Leonard B. Saltz, Julio Garcia-Aguilar, Richard Koche, Scott W. Lowe, Dana Pe’er, Jinru Shia, Joan Massagué
Journal: Nature Cancer (2020)
Association of Baseline Corticosteroid with Outcomes in a Multivariate Analysis of the Phase 3 Affirm Study of Enzalutamide (ENZA), An Androgen Receptor Signaling Inhibitor (ARSI)
Authors: H.I. Scher, K. Fizazi, F. Saad, K. Chi, M. Taplin, C.N. Sternberg, A.J. Armstrong, M. Hirmand, B. Selby, J.S. de Bono
Journal: Annals of Oncology (2012)
The Impact of Valproic Acid in Overall Survival of Patients with Glioblastoma Multiforme
Authors: S.R. Meireles, M.L. Salgado, D. Almeida, L. Castro, P. Linhares, L. Osório, A.S.A. Costa, C. Caeiro, M. Damasceno
Journal: Annals of Oncology (2012)
Connecting With Patients—The Missing Links
Authors: Lisa Sanders, Auguste H. Fortin, Gordon D. Schiff
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Authors: Naomi E. Wijker, Suzanna Vidmar, Keith Grimwood, Peter D. Sly, Catherine A. Byrnes, John B. Carlin, Peter J. Cooper, Colin F. Robertson, R. John Massie, Mariette P.C. Kemner van de Corput, Joyce Cheney, Harm A.W.M. Tiddens, Claire E. Wainwright
Journal: European Respiratory Journal (2020)

Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This study examined early predictors of progressive structural lung abnormalities in children who completed the Australasian CF Bronchoalveolar Lavage (ACFBAL) clinical trial at age 5-years and participated in an observational follow-up study (CF-FAB).Eight Australian and New Zealand CF centres participated in CF-FAB and provided follow-up chest computed-tomography (CT) scans for children who had completed the ACFBAL study with baseline scans at age 5-years. CT scans were annotated using PRAGMA-CF scoring. Ordinal regression analysis and linear regression were used to investigate associations between PRAGMA-CF (Perth-Rotterdam Annotated Grid Morphometric Analysis for CF) outcomes at follow-up and variables measured during the ACFBAL study.99 out of 157 ACFBAL children (mean±sd age 13±1.5 years) participated in the CF-FAB study. The probability of bronchiectasis at follow-up increased with airway disease severity on the baseline CT scan. In multiple regression (retaining factors at p<0.05) the extent of bronchiectasis at follow-up was associated with baseline atelectasis (OR 7.2, 95% CI 2.4-22; p≤ 0.001), bronchoalveolar lavage (BAL) log2 interleukin (IL)-8 (OR 1.2, 95% CI 1.05-1.5; p=0.010) and body mass index z-score (OR 0.49, 95% CI 0.24-1.00; p=0.05) at age 5 years. Percentage trapped air at follow-up was associated with BAL log2 IL-8 (coefficient 1.3, 95% CI 0.57-2.1; p<0.001) at age 5 years.The extent of airway disease, atelectasis, airway inflammation and poor nutritional status in early childhood are risk factors for progressive structural lung disease in adolescence.
Granite-1; Phase III Trial of Everolimus (EVE) in Previously Treated Patients with Advanced Gastric Cancer (AGC): Results of Japanese Population
Authors: K. Chin, K. Muro, T. Doi, E. Warita, T. Kudo, T. Nishina, J. Furuse, Y. Komatsu, K. Yamaguchi, S. Kato, H. Takiuchi, W. Koizumi, T. Sahmoud, N. Ohno, A. Ohtsu
Journal: Annals of Oncology (2012)
Blood Lead Levels in U.S. Women of Childbearing Age, 1976–2016
Authors: Adrienne S. Ettinger, Kathryn B. Egan, David M. Homa, Mary Jean Brown
Journal: Environmental Health Perspectives (2020)

Background: Lead can adversely affect maternal and child health across a wide range of exposures; developing fetuses and breastfeeding infants may be particularly vulnerable. We describe the distribution of blood lead levels (BLLs) in U.S. women of childbearing age and associations with sociodemographic, reproductive, smoking, and housing characteristics over a 40-y period. Methods: Data from the National Health and Nutrition Examination Survey (NHANES) II, NHANES III Phase I and Phase II, and 1999–2016 continuous NHANES were used to describe the distribution of BLLs (given in micrograms per deciliter; 1μg/dL=0.0483μmol/L) in U.S. women 15–49 years of age between 1976 and 2016. For all women with valid BLLs (n=22,408), geometric mean (GM) BLLs and estimated prevalence of BLLs ≥5μg/dL were calculated overall and by selected demographic characteristics. For NHANES II, estimated prevalence of BLLs ≥10 and ≥20μg/dL were also calculated. Results: The most recent GM BLLs (2007–2010 and 2011–2016, respectively) were 0.81μg/dL [95% confidence interval (CI): 0.79, 0.84] and 0.61μg/dL (95% CI: 0.59, 0.64). In comparison, GM BLLs in earlier periods (1976–1980, 1988–1991, and 1991–1994) were 10.37μg/dL (95% CI: 9.95, 10.79), 1.85μg/dL (95% CI: 1.75, 1.94), and 1.53μg/dL (95% CI: 1.45, 1.60), respectively. In 2011–2016, 0.7% of women of childbearing age had BLLs ≥5μg/dL, and higher BLLs were associated with older age, other race/ethnicity, birthplace outside the United States, four or more live births, exposure to secondhand tobacco smoke, and ever pregnant or not currently pregnant. Discussion: Lead exposure in U.S. women of childbearing age is generally low and has substantially decreased over this 40-y period. However, based on these estimates, there are still at least 500,000 U.S. women being exposed to lead at levels that may harm developing fetuses or breastfeeding infants. Identifying high-risk women who are or intend to become pregnant remains an important public health issue. https://doi.org/10.1289/EHP5925
Abstract 14559: Metabolites Associated With Per- and Polyfluoroalkyl Substance (PFAS) Levels in an Ethnically Diverse Underserved At-Risk Rural Population
Authors: Jawan W Abdulrahim, Heather M Stapleton, Maggie Nguyen, Lydia C Kwee, Olga Ilkayeva, Cherry M Beasley, John W Stanifer, Svati H Shah
Journal: Circulation (2019)

Per- and polyfluoroalkyl substances (PFASs) are manufactured compounds used in a number of consumer products and have been linked to several health conditions. In North Carolina (NC), vulnerable po...
Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5
Authors: Xiang Zhao, Dan Li, Feng Yang, Heng Lian, Jianqun Wang, Xiaojing Wang, Erhu Fang, Huajie Song, Anpei Hu, Yanhua Guo, Yang Liu, Hongjun Li, Yajun Chen, Kai Huang, Liduan Zheng, Qiangsong Tong
Journal: Molecular Therapy (2020)

Recent studies suggest that long noncoding RNAs (lncRNAs) play essential roles in tumor progression. However, the functional roles and underlying mechanisms of lncRNAs in neuroblastoma (NB), the most common malignant solid tumor in pediatric population, still remain elusive. Herein, through integrating analysis of a public RNA sequencing dataset, neuroblastoma highly expressed 1 (NHEG1) was identified as a risk-associated lncRNA, contributing to an unfavorable outcome of NB. Depletion of NHEG1 led to facilitated differentiation and decreased growth and aggressiveness of NB cells. Mechanistically, NHEG1 bound to and stabilized DEAD-box helicase 5 (DDX5) protein through repressing proteasome-mediated degradation, resulting in β-catenin transactivation that altered target gene expression associated with NB progression. We further determined a lymphoid enhancer binding factor 1 (LEF1)/transcription factor 7-like 2 (TCF7L2)/NHEG1/DDX5/β-catenin axis with a positive feedback loop and demonstrated that NHEG1 harbored oncogenic properties via its interplay with DDX5. Administration of small interfering RNAs against NHEG1 or DDX5 reduced tumor growth and prolonged survival of nude mice bearing xenografts. High NHEG1 or DDX5 expression was associated with poor survival of NB patients. These results indicate that lncRNA NHEG1 exhibits oncogenic activity that affects NB progression via stabilizing the DDX5 protein, which might serve as a potential therapeutic target for NB.
T790M Resistant Mutation in Plasma of Acquired Resistant EGFR Mutated Non Small Cell Lung Cancer (Nsclc) Patients - The Tarzo Trial (NCT00503971)
Authors: N. Reguart, E. Nadal, M.A. Molina, E. Carcereny, C. Queralt, A. Insa Molla, I. Aguirre, M. Taron, D. Isla Casado, R. Rosell
Journal: Annals of Oncology (2012)
Rituximab Plus Subcutaneous Cladribine in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa Associated Tissue (MALT-LYMPHOMA): A Phase II Study by the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)
Authors: M. Troch, B. Kiesewetter, W. Willenbacher, E. Willenbacher, A. Zebisch, W. Linkesch, M.A. Fridrik, L. Müllauer, R. Greil, M. Raderer
Journal: Annals of Oncology (2012)
Neoadjuvant Gemox Followed by Gem-Based Chemoradiation for Locally advanced Unresectable Pancreatic Cancer
Authors: V. Vaccaro, I. Sperduti, E. Bria, B. Saracino, M.S. Pino, G. Grazi, A. Gelibter, G. Vallati, F. Cognetti, M. Milella
Journal: Annals of Oncology (2012)
Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine
Authors: Kenji Ohshima, Satoshi Nojima, Shinichiro Tahara, Masako Kurashige, Keisuke Kawasaki, Yumiko Hori, Moyu Taniguchi, Yutaka Umakoshi, Daisuke Okuzaki, Naoki Wada, Jun-ichiro Ikeda, Eiichiro Fukusaki, Eiichi Morii
Journal: Nature Metabolism (2020)
Mammalian Target of Rapamycin Inhibitors Versus Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors (VEGF TKI) as Second-Line Therapy in Patients with Metastatic Renal Cell Carcinoma after Failure of First-Line VEGF TKI: Single Center Retrospective Analysis
Authors: J.-L. Lee, K. Park, I. Park, S. Park, Y. Ahn, J.-H. Ahn, C. Song, J.H. Hong, C.-S. Kim, H. Ahn
Journal: Annals of Oncology (2012)
Vinorelbine Plus Cisplatin Versus Gefitinib in Resected Non-Small-Cell Lung Cancer Haboring Activating EGFR Mutation (WJOG6410L)
Authors: H. Tada, K. Takeda, K. Nakagawa, I. Okamoto, T. Mitsudomi, Y. Ichinose, K. Sugio, M. Tsuboi, Y. Nakanishi
Journal: Annals of Oncology (2012)